Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication. Phase 1 clinical trial of the patent-pending, rapid-onset ...

A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...

A majority of patients with Parkinson disease (PD) experiencing "off" episodes successfully tolerated titration to an effective and tolerable dose of sublingual apomorphine film (SL-apo; Kynmobi, ...

Buprenorphine sublingual tablet is prescribed to treat opioid use disorder in two phases: an induction phase to manage initial withdrawal symptoms and a maintenance phase for long-term treatment. You ...

Zubsolv (buprenorphine/naloxone) is a brand-name sublingual tablet that’s prescribed for opioid use disorder. As with other drugs, Zubsolv can cause side effects. These include opioid withdrawal ...

Please provide your email address to receive an email when new articles are posted on . Researchers called this the first study among children aged 1 to 4 years. The treatment group saw improved ...

Samson Clinical Operations Pty Ltd (Samson) announced completion of the Last Patient Last Visit in its pivotal Phase III clinical trial evaluating low dose sublingual minoxidil in male Androgenetic ...

TNX-102 SL is intended to be taken once at bedtime for the management of fibromyalgia. Treatment with TNX-102 SL (cyclobenzaprine HCl sublingual tablets) significantly reduced daily pain in patients ...

Please provide your email address to receive an email when new articles are posted on . Researchers confirmed that epinephrine can reach therapeutic plasma concentrations via sublingual administration ...

The US Food and Drug Administration (FDA) has approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film for the treatment of opioid dependence, which may increase ...

A novel formulation of the muscle relaxant drug cyclobenzaprine has won FDA approval for treating fibromyalgia, manufacturer Tonix Pharmaceuticals announced on Friday. To be sold as Tonmya, the ...